Tue.Apr 09, 2024

article thumbnail

Amid corporate restructuring, Novartis plots 680 layoffs in development group

Fierce Pharma

Even as Novartis rolls ahead with a global restructuring campaign targeting thousands of job cuts, the Swiss drug giant has blueprinted several hundred layoffs in its development organizational uni | Even as Novartis rolls ahead with a global restructuring campaign targeting thousands of job cuts, the Swiss drug giant has blueprinted several hundred layoffs in its development organizational unit.

293
293
article thumbnail

How Can Healthcare Ensure Responsible AI Use?

MedCity News

At a recent conference, executives from across the industry shared their thoughts on how the healthcare sector can ensure its use of AI is ethical and responsible. They highlighted the need for collaboration, trust building and pragmatic thinking. The post How Can Healthcare Ensure Responsible AI Use? appeared first on MedCity News.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

As FDA weighs another myeloma endpoint for accelerated approvals, experts say timely access is at stake

Fierce Pharma

About 15 years ago, Carl Ola Landgren, M.D. Ph.D., noticed an encouraging yet potentially concerning trend in the treatment of multiple myeloma. | At an FDA advisory committee meeting this Friday, two teams will present their studies examining the utility of minimal residue disease (MRD) as a potentially approvable endpoint in multiple myeloma. For this report, Fierce Pharma spoke with experts to learn about what's at stake, including the need to bring new treatments to patients earlier.

FDA 282
article thumbnail

Pelago Unveils Contingency Management Program To Support Those With Substance Use Disorder

MedCity News

Pelago’s new contingency management program rewards patients for engaging in treatment, such as completing a survey, completing app check-ins, attending appointments and completing cognitive behavioral therapy exercises. The post Pelago Unveils Contingency Management Program To Support Those With Substance Use Disorder appeared first on MedCity News.

article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Advanced therapy CDMO Ascend nabs Florida manufacturing site and team from ocular gene therapy outfit Beacon

Fierce Pharma

Though gene therapy manufacturing specialist Ascend Advanced Therapies just launched a little more than a year ago, the CDMO is already on the hunt to expand. | Ascend, which bills itself as a “total solutions gene therapy development partner,” has picked up the manufacturing team and site of Beacon Therapeutics in Alachua, Florida. As part of the deal, Ascend has also agreed to a long-term partnership with Beacon to produce its ocular gene therapies for clinical and commercial use.

article thumbnail

NHS trust bids to take license for abandoned gene therapy

pharmaphorum

Great Ormond Street Hospital is applying for the license to a gene therapy for rare disease ADA-SCID that was abandoned by a biotech developer on commercial grounds.

119
119

More Trending

article thumbnail

PureTech Startup Gets $100M to Try For Success Where Sage & Others Fall Short in Depression

MedCity News

Seaport Therapeutics’ drug candidates are delivered through the lymphatic system, an approach that could overcome some limitations of neuropsychiatric medicines, including products from Sage Therapeutics. The startup stems from the research of PureTech Health. The post PureTech Startup Gets $100M to Try For Success Where Sage & Others Fall Short in Depression appeared first on MedCity News.

Medicine 115
article thumbnail

AACR: Detailed data spark glimmer of hope for Merck's Keytruda-Lynparza combo in lung cancer

Fierce Pharma

Researchers plan to run biomarker analyses of patients in the KEYLYNK-008 trial to see whether any subsets may benefit from the addition of Lynparza.

Patients 248
article thumbnail

Which Health Tech Startups Will Present in the Payer/Provider Track of INVEST Pitch Perfect?

MedCity News

The finalists for the Payer/Provider track are applying their health tech solutions to addressing burnout and operational efficiency. The post Which Health Tech Startups Will Present in the Payer/Provider Track of INVEST Pitch Perfect? appeared first on MedCity News.

109
109
article thumbnail

UK survey finds deep ethnic divisions in cancer diagnosis

pharmaphorum

A UK report has found that people from minority ethnic backgrounds face an average delay of a year between first noticing symptoms and gaining a diagnosis, which is more than twice as long as white people.

102
102
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Women in Leadership: 4 Key Takeaways for the Career Journey

ALULA

It’s been somewhat of an annual tradition for me to attend the Women in Leadership panel at the American Manufacturing Summit and share the highlights. This year’s panel discussion brought together five senior leaders: Joy Malinowski from Constellation Brands, Elena Bernado from Hello Fresh, Susanne Lauda from AGCO, Donna Deyo from Paccar, and Angela Reamer from Monin.

article thumbnail

Achieving FAIR bacterial identification

European Pharmaceutical Review

Research published in Biosensors reports the strong potential of using 3D printed substrates in bacterial analysis. The study by Childs et al. utilised a rapid 3D printed µbiochamber with a laser-ablated interdigitated electrode. This system was developed for biofilm analysis of Pseudomonas aeruginosa , Acinetobacter baumannii and Bacillus subtilis using electrochemical biological impedance spectroscopy (EBIS) across a four-hour spectrum.

Media 98
article thumbnail

Ex-Karuna team launch Seaport with $100m for psychiatry meds

pharmaphorum

The team that brought you Karuna, recently sold to Bristol-Myers Squibb for $14 billion, has set up a neuropsychiatry-focused biotech called Seaport Therapeutics

94
article thumbnail

Europa Perspectives on Lifecycle Management

PharmaTech

In this latest installment of the Europa Perspectives series, Alexander Natz, Secretary General at EUCOPE, delves into the European Commission’s new measures aimed at making lifecycle management more efficient across the European Union.

article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

Ubie AI aims to improve diagnosis of rare disease Cushing’s

pharmaphorum

People with Cushing’s syndrome can sometimes take years to get a diagnosis, but a new project hopes to shorten that timeline with the help of artificial intelligence.

88
article thumbnail

US researchers reveal positive results of personalised vaccine for liver cancer

PharmaTimes

Hepatocellular carcinoma is one of the leading causes of cancer-related deaths worldwide

Leads 101
article thumbnail

Bayer, Google partner on AI for time-pressed radiologists

pharmaphorum

Bayer enlists the aid of Google Cloud to develop its AI platform for radiologists, adding genAI capabilities

108
108
article thumbnail

Culmination Bio and BillionToOne partner to advance cancer diagnosis

PharmaTimes

Both will validate the clinical performance of two new diagnostic tests for regulatory submission

95
article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

USA Today Names CCC a Top Workplace for Third Year in a Row

Copyright Clearance Center

April 9, 2024 – Danvers, Mass. – CCC , a leader in advancing copyright, accelerating knowledge, and powering innovation, has been named to the Top Workplaces USA 2024 list by USA Today for the third consecutive year. The Top Workplaces USA awards offer recognition to mid-size and large organizations with at least 150 employees, including those with operations in multiple geographic markets.

article thumbnail

Biosimilar uptake appears to finally be on the upswing, and Biocon Biologics is betting on the sector’s future

PharmaVoice

Biosimilars promise market competition for branded biologics, which in theory could drive down prices. But so far, winning market share has been a struggle.

article thumbnail

Celebrating Eidul Fitr 2024: Embracing Our Moments of Joy and Gratitude

Contrarian Sales Techniques

As the moon heralds the arrival of Eidul Fitr this April, it's not just a celebration marking the end of Ramadan, but a moment of reflection and gratitude for the journey we've embarked upon in 2024. This year, amidst its challenges and rewards, has been a testament to the resilience and spirit of our community. As we gather with our loved ones to celebrate this joyous occasion, it's a poignant reminder of the beauty of the present moment and the myriad reasons we have to be grateful.

article thumbnail

Pharma’s drumbeat to justify drug prices is at odds with consumer sentiments

PharmaVoice

More than 20% of Americans are forgoing prescription medications due to costs, but the industry continues to fight policy measures.

article thumbnail

Increase Revenue With Better, Faster Sales Onboarding

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

article thumbnail

Ethical and Regulatory Issues with Weight Loss Companies

PharmExec

In this Pharmaceutical Executive video interview, Currax Pharmaceuticals, CEO, George Hampton, talks about the ethical and regulatory problems weight loss companies like WW, Noom, and Ro present.

Ethics 52
article thumbnail

Memel Biotech to Offer ATMP Manufacturing at Lithuania Site

PharmaTech

With the launch of a new manufacturing service, Memel Biotech will offer services for discovery through to formulation for advance therapy medicinal products.

article thumbnail

Bristol Myers Squibb Reveals Promising Data for KarXT, a Potential Treatment for Schizophrenia

PharmExec

A combination of data from the EMERGENT-4 trial and pooled data from the EMERGENT program showed the promise of KarXT (xanomeline-trospium) in providing symptom improvement for people with schizophrenia.

52
article thumbnail

FDA gives nod to BrainStorm for ALS trial after Phase III flop

Pharmaceutical Technology

BrainStorm Cell Therapeutics has faced a few hurdles along the way towards the development of its lead candidate, NurOwn for ALS.

FDA 59
article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

Lonza, NeuroSense Strike Deal Focused on Exploring Biological Markers for Neurodegenerative Diseases

PharmExec

Collaboration aims to advance the development of treatments for multiple neurodegenerative conditions, including amyotrophic lateral sclerosis.

52
article thumbnail

Pfizer meets Phase III primary endpoints for RSV vaccine Abrysvo

Pharmaceutical Technology

Pfizer intends to submit data from MONeT to regulatory agencies in a bid to expand the vaccine’s indicated treatment population.

59
article thumbnail

Newest Indication for Bempedoic Acid Expands Patient Population

Pharmacy Times

In March 2024, the label for bempedoic acid was expanded to reduce cardiovascular risk and expand the low-density lipoprotein-C (LDL-C) lowering in both primary and secondary prevention patients.

article thumbnail

Blue Cross to Increase Reimbursements to Small, Independent Practices in Massachusetts

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52
article thumbnail

Using Generative AI in Sales: Pros, Cons, and Considerations According to Sellers

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A